These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 34478947)

  • 1. Monophosphoryl lipid A directly regulates Th1 cytokine production in human CD4
    Komai-Koma M; Ji Y; Cao H; Liu Z; McSharry C; Xu D
    Immunobiology; 2021 Sep; 226(5):152132. PubMed ID: 34478947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Toll-like receptor 4 agonist monophosphoryl lipid a augments innate host resistance to systemic bacterial infection.
    Romero CD; Varma TK; Hobbs JB; Reyes A; Driver B; Sherwood ER
    Infect Immun; 2011 Sep; 79(9):3576-87. PubMed ID: 21646453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced antigen-specific primary CD4+ and CD8+ responses by codelivery of ovalbumin and toll-like receptor ligand monophosphoryl lipid A in poly(D,L-lactic-co-glycolic acid) nanoparticles.
    Hamdy S; Elamanchili P; Alshamsan A; Molavi O; Satou T; Samuel J
    J Biomed Mater Res A; 2007 Jun; 81(3):652-62. PubMed ID: 17187395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monophosphoryl lipid A induces protection against LPS in medullary thick ascending limb through a TLR4-TRIF-PI3K signaling pathway.
    Watts BA; George T; Sherwood ER; Good DW
    Am J Physiol Renal Physiol; 2017 Jul; 313(1):F103-F115. PubMed ID: 28356284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contribution of TLR4 and MyD88 for adjuvant monophosphoryl lipid A (MPLA) activity in a DNA prime-protein boost HIV-1 vaccine.
    Pouliot K; Buglione-Corbett R; Marty-Roix R; Montminy-Paquette S; West K; Wang S; Lu S; Lien E
    Vaccine; 2014 Sep; 32(39):5049-56. PubMed ID: 25045815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Novel Prime and Boost Regimen of HIV Virus-Like Particles with TLR4 Adjuvant MPLA Induces Th1 Oriented Immune Responses against HIV.
    Poteet E; Lewis P; Li F; Zhang S; Gu J; Chen C; Ho SO; Do T; Chiang S; Fujii G; Yao Q
    PLoS One; 2015; 10(8):e0136862. PubMed ID: 26312747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of an intranasal virosomal respiratory syncytial virus vaccine adjuvanted with monophosphoryl lipid A in mice and cotton rats.
    Kamphuis T; Shafique M; Meijerhof T; Stegmann T; Wilschut J; de Haan A
    Vaccine; 2013 Apr; 31(17):2169-76. PubMed ID: 23499594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccination with toxofilin DNA in combination with an alum-monophosphoryl lipid A mixed adjuvant induces significant protective immunity against Toxoplasma gondii.
    Song P; He S; Zhou A; Lv G; Guo J; Zhou J; Han Y; Zhou H; Hao Z; Cong H
    BMC Infect Dis; 2017 Jan; 17(1):19. PubMed ID: 28056837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Fusion Protein Consisting of the Vaccine Adjuvant Monophosphoryl Lipid A and the Allergen Ovalbumin Boosts Allergen-Specific Th1, Th2, and Th17 Responses In Vitro.
    Schülke S; Vogel L; Junker AC; Hanschmann KM; Flaczyk A; Vieths S; Scheurer S
    J Immunol Res; 2016; 2016():4156456. PubMed ID: 27340679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of tolerogenic vs immunogenic dendritic cells (DCs) in the presence of GM-CSF is regulated by the strength of signaling from monophosphoryl lipid A (MPLA) in association with glutathione and fetal hemoglobin gamma-chain.
    Khatri I; Alexander C; Brandenburg K; Fournier K; Mach JP; Rietschel ET; Ulmer AJ; Terzioglu E; Waelli T; Gorczynski RM
    Immunol Lett; 2009 May; 124(1):44-9. PubMed ID: 19379773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MPLA shows attenuated pro-inflammatory properties and diminished capacity to activate mast cells in comparison with LPS.
    Schülke S; Flaczyk A; Vogel L; Gaudenzio N; Angers I; Löschner B; Wolfheimer S; Spreitzer I; Qureshi S; Tsai M; Galli S; Vieths S; Scheurer S
    Allergy; 2015 Oct; 70(10):1259-68. PubMed ID: 26081583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monophosphoryl lipid A coating of hydroxyethyl starch nanocapsules drastically increases uptake and maturation by dendritic cells while minimizing the adjuvant dosage.
    Fichter M; Dedters M; Pietrzak-Nguyen A; Pretsch L; Meyer CU; Strand S; Zepp F; Baier G; Landfester K; Gehring S
    Vaccine; 2015 Feb; 33(7):838-46. PubMed ID: 25573037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AS04, an aluminum salt- and TLR4 agonist-based adjuvant system, induces a transient localized innate immune response leading to enhanced adaptive immunity.
    Didierlaurent AM; Morel S; Lockman L; Giannini SL; Bisteau M; Carlsen H; Kielland A; Vosters O; Vanderheyde N; Schiavetti F; Larocque D; Van Mechelen M; Garçon N
    J Immunol; 2009 Nov; 183(10):6186-97. PubMed ID: 19864596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of humoral and cellular immune responses by monophosphoryl lipid A (MPLA) as an adjuvant to the rabies vaccine in BALB/c mice.
    Hu X; Liu R; Zhu N
    Immunobiology; 2013 Dec; 218(12):1524-8. PubMed ID: 23816301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monophosphoryl lipid A induces protection against LPS in medullary thick ascending limb through induction of Tollip and negative regulation of IRAK-1.
    Watts BA; Tamayo E; Sherwood ER; Good DW
    Am J Physiol Renal Physiol; 2019 Sep; 317(3):F705-F719. PubMed ID: 31241993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Small Molecule Potentiator of Adjuvant Activity Enhancing Survival to Influenza Viral Challenge.
    Saito T; Sako Y; Sato-Kaneko F; Hosoya T; Yao S; Lao FS; Shpigelman J; Messer K; Pu M; Shukla NM; Chan M; Chu PJ; Cottam HB; Hayashi T; Carson DA; Corr M
    Front Immunol; 2021; 12():701445. PubMed ID: 34650551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of hyaluronic acid-based combination adjuvant containing monophosphoryl lipid A and aluminum salt for hepatitis B vaccine.
    Moon SH; Shin EC; Noh YW; Lim YT
    Vaccine; 2015 Sep; 33(38):4762-9. PubMed ID: 26271830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelial cell tolerance to lipopolysaccharide challenge is induced by monophosphoryl lipid A.
    Stark RJ; Choi H; Koch SR; Fensterheim BA; Lamb FS; Sherwood ER
    Clin Sci (Lond); 2016 Mar; 130(6):451-61. PubMed ID: 26669797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monophosphoryl lipid A inhibits the cytokine response of endothelial cells challenged with LPS.
    Stark R; Choi H; Koch S; Lamb F; Sherwood E
    Innate Immun; 2015 Aug; 21(6):565-74. PubMed ID: 25540284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific features of human monocytes activation by monophosphoryl lipid A.
    Chentouh R; Fitting C; Cavaillon JM
    Sci Rep; 2018 May; 8(1):7096. PubMed ID: 29728623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.